We recently identified a novel ABC A subclass transporter, ABCA6, in human macrophages. Here, we report the molecular cloning of an additional ABC A subfamily transporter from macrophages denoted ABCA9. The identified coding sequence is 4.9 kb in size and codes for a 1624 amino acid protein product. In accordance with the proposed nomenclature, the novel transporter was designated ABCA9. The putative full-length ABC transporter polypeptide consists of two transmembrane domains and two nucleotide binding folds and thus conforms to the group of full-size ABC transporters. We identified alternative ABCA9 mRNA variants in human macrophages that predict the existence of three truncated forms of the novel transporter. Among the human ABC A subfamily transporters, ABCA9 exhibits the highest amino acid sequence homology with ABCA8 (72%) and ABCA6 (60%), respectively. The striking amino acid sequence similarity between these transporter molecules supports the notion that they represent an evolutionary more recently emerged subgroup within the family of ABC A transporters, which we refer to as ''ABCA6-like transporters.'' ABCA9 mRNA is ubiquitously expressed with the highest mRNA levels in heart, brain, and fetal tissues. Analysis of the genomic structure revealed that the ABCA9 gene consists of 39 exons that are located within a genomic region of $85 kb size on chromosome 17q24.2. In human macrophages, ABCA9 mRNA is induced during monocyte differentiation into macrophages and suppressed by cholesterol import indicating that ABCA9, like other known ABC A subfamily transporters, is a cholesterol-responsive gene. Based on this information, ABCA9 is likely involved in monocyte differentiation and macrophage lipid homeostasis. Ó
ATP-binding cassette (ABC) transporters constitute a complex group of structurally related multispan transmembrane proteins that mediate the translocation of a broad spectrum of substrates across cellular membranes. These include ions, peptides, sugars, vitamins, and steroid hormones [1, 2] . The subgroup of full-size ABC transporters is structurally characterized by two nucleotide binding folds (NBF) with conserved Walker A and B motifs, signature sequences, and two transmembrane domains, each typically composed of six membranespanning segments [3] . The specificity for the transported substrates is thought to be determined by the transmembrane domains, whereas the energy required for the transmembrane transport is provided by hydrolysis of ATP at the two NBF [4] . In the past, some ABC transporters have been studied extensively based on the observation that they are capable of mediating multidrug resistance in cancer therapy.
In the recent years, evidence has accumulated to suggest that ABC transporters serve important physiological functions in the cellular transmembrane transport of endogenous lipid substrates [5, 6] . This concept has been supported by work from our laboratory and others providing evidence that ABCA1, the prototypic member of the ABC A subfamily [2] , is a major regulator of HDL in the circulation which functions as a facilitator of cellular phospholipid and cholesterol export [7] [8] [9] [10] . Interestingly, leukocyte ABCA1 has been shown to directly control the recruitment of macrophages into tissues and the progression of lesions of atherosclerosis [11] . Beside ABCA1, the half-size transporter ABCG1 has been implicated in macrophage cholesterol and phospholipid export [12] . The recent BBRC finding that mutations in the half-size transporters ABCG5 and ABCG8 cause b-sitosterolemia, a rare autosomal recessive disorder which is characterized by hyperabsorption of sterols, hypercholesterolemia, decreased biliary excretion of dietary sterols, and premature coronary atherosclerosis [13] , has demonstrated a role for ABC transporters in intestinal sterol uptake [14, 15] .
We have recently cloned additional members of the ABC A-subclass of transporters from human macrophages [16] [17] [18] . Among these, ABCA7 and ABCA2 exhibit significant homology with the phospholipid and cholesterol export facilitator ABCA1. ABCA7 is strongly expressed in tissues that are rich in macrophages and lymphocytes including bone marrow, thymus, spleen, and peripheral blood [16] . In contrast, ABCA2 shows the highest expression in neurologic tissues [19] . The observation that ABCA2 and ABCA7 are co-regulated with ABCA1 in response to cholesterol uptake and efflux [16, 17, 20] suggests roles for these transporters in macrophage lipid trafficking. In a recent study, we identified an additional member of the ABC A-subfamily, designated ABCA6, which is upregulated during monocyte differentiation into human macrophages [18] . However, unlike ABCA1, ABCA2, and ABCA7, the expression of this novel transporter is suppressed during cholesterol uptake of macrophages [12] .
In the present study, we report the complete coding sequence and genomic structure of the human ABCA9 gene. We demonstrate that the molecular structure of ABCA9 is highly similar to those of ABCA8 and ABCA6, respectively, and provide evidence for sterol-dependent regulation of ABCA9 in human macrophages.
Materials and methods
Cell culture and preparation of enzymatically degraded, nonoxidized LDL. Human monocytes were obtained from healthy donors by leukapheresis and counterflow elutriation [12] . Aliquots of 10 8 cells were cultured on plastic petri dishes in macrophage SFM medium (Gibco BRL, Karlsruhe) and allowed to differentiate into macrophages for four days in the presence of 50 ng/ml recombinant human M-CSF (R&D Systems, Wiesbaden) [12] . Macrophages were incubated in the presence of enzymatically modified LDL (eLDL, 40 lg/ml) to induce sterol loading for an additional 24 h. LDLs (d ¼ 1.006-1.063 g/ml) were purified from human plasma obtained from healthy volunteers according to published standard protocols [12] . The preparation was performed in a Beckman L-70 ultracentrifuge (70 Ti rotor) at 4°C and densities were adjusted with solid KBr. Lipoprotein fractions were dialyzed repeatedly in phosphate-buffered saline (PBS) containing 5 mM EDTA. After the final dialysis step (0.15 M NaCl), LDL lipoproteins were sterilized using a 0.45 lm sterile filter (Sartorius, G€ o ottingen). Enzymatically degraded, nonoxidized LDL (eLDL) was prepared according to the protocol by Bhakdi et al. [21] .
Nucleic acid purification. Total cellular RNA was isolated from monocytes/macrophages by guanidium isothiocyanate lysis and CsCl centrifugation [22] and RNA was quantitated spectrophotometrically. For preparation of genomic DNA, leukocytes were prepared from 50 ml human venous blood (anti-coagulated with EDTA) by centrifugation at 400g. Genomic DNA was extracted from whole cells using the Qiamp DNA Blood Midi Kit (Qiagen, Hilden).
Cloning of human ABCA9 full-length cDNA. Total RNA from human mononuclear phagocytes that were allowed to differentiate for four days [12] was prepared and aliquots of 1 lg were reverse-transcribed in a 20 ll RT reaction using the first Strand cDNA Synthesis Kit for RT-PCR (AMV) (Roche, Mannheim). cDNA was amplified in a 50 ll reaction volume using the Taq PCR Core Kit (Qiagen, Hilden) (cycle profile: 94°C for 20 s, 52-62°C for 45 s, and 72°C for 2-3 min). ABCA9-specific PCR segments were amplified utilizing sets of degenerated primers homologous to areas with high similarity between the coding regions of ABCA6 and ABCA8, respectively. The sequences of multiple PCR products contained unique open reading frames and displayed high overall homology with human ABCA8 and ABCA6, respectively. Using primers specific for the identified sequence fragments, the missing interspersed segments were amplified. The assembled overlapping amplification products contained an open reading frame which represented the complete coding region of a novel ABC A-subclass transporter. The flanking ends of the thus identified cDNA were PCR cloned using degenerated primers from regions of maximum homology between ABCA8 and ABCA6. All amplification reactions were sequenced at least in triplicate.
Amplification primers which resulted in the identification of alternative mRNA splice variants were 5 0 -ATGAAGAACAATCATGG GGTGGCCT-3 0 (forward), 5 0 -AGACCATCACAAAACCAGTCAG GACGA-3 0 (reverse) (ABCA9D + 55), and 5
0 (reverse) (ABCA9D + 73, ABCA9D ) 95), respectively. Semiquantitative RT-PCR. Semiquantitative RT-PCR was performed as previously published [12] . For this, the ABCA9-specific primers were used (5 0 -ATGAAGAACAATCATGGGGTGGCCT-3 0 , forward; 5 0 -AGACCATCACAAAACCAGTCAGGACGA-3 0 , reverse) yielding a diagnostic fragment of 607 and 662 bp, respectively, representing the alternatively spliced ABCA9D + 55 transcript size. Equal amounts of input RNA were reverse-transcribed and amplified for 25, 30, and 35 cycles, respectively, to monitor that the PCR was in the exponential phase. Amplification of the housekeeping gene GAPDH served to normalize input RNA amounts (not shown) [17] .
PCR amplification of intron sequences. PCR cloning of intron sequences was performed using the Taq PCR Core Kit (Qiagen, Hilden) and putative exon-specific oligonucleotide primers for ABCA9 based on gene structure information of ABCA6 [18] . One hundred to five hundred nanogram aliquots of genomic DNA were amplified in a 50 ll reaction volume. The reaction mix was composed of 500 nM oligonucleotide primers, 1.5-3 mM MgCl 2 , 200 lM dNTP, 10Â Qiagen PCR buffer, and 2 units Taq DNA polymerase (Qiagen, Hilden). After a 2 min denaturation step (94°C), reaction mixtures were PCR amplified for 40 cycles using the following cycle profile: 94°C for 20 s, 60-65°C for 45 s, and 72°C for 5 min. Large introns were amplified using the Expand Long Template PCR System (Roche, Mannheim) (according to manufacturer's manual). All PCR amplification products were separated on ethidium bromide stained agarose gels. Bands of interest were excised and the DNA was extracted using the GFX PCR DNA Purification Kit (Amersham, Piescataway) for subsequent sequence analysis.
DNA sequencing. Both strands of GFX purified PCR products were sequenced on an ABI Prism 310 capillary sequencer (PE Applied Biosystems, Weiterstadt) as previously described [16] . Cycle-sequencing reactions were performed with BigDye terminators (DNA Sequencing Kit, PE Applied Biosystems), purified on CentriSep spin columns, and analyzed by capillary electrophoresis.
Analysis of ABCA9 mRNA expression in human tissues. The tissuespecific expression of ABCA9 was characterized using a multiple tissue RNA master blot containing poly A þ RNA from various human tissues (Clontech, Heidelberg). A 0.5-kb probe was generated by RT-PCR using primers that were derived from a region of minimal homology between ABCA9, ABCA8, and ABCA6, respectively.
The PCR primers used were: 5 0 -AGCGTGGGTCAGCAAACATG-3 0 (forward) and 5 0 -TTCTCCCAGAACTCTGAACC-3 0 (reverse), respectively. For signal detection, the probe was radiolabeled with [a-32 P]dCTP (Amersham, Freiburg; Oligolabeling Kit, Pharmacia, Freiburg) and hybridization and washing were performed according to published protocols [23] . Subsequently, the tissue blot was quantitated densitometrically and the individual signal densities were translated into a linear integer scale ranging from 0 to 4 (0, no expression; 4, maximum expression) as described previously [18, 20] .
Computer sequence analyses. For DNA and protein computer analyses, the WWW 2 HUSAR GCG software package (DKFZ, Heidelberg) was used. Sequence comparisons and protein alignments were performed using the FASTA and MOTIFS applications, respectively.
Results and discussion
In this study, we report the identification of the complete cDNA sequence and the characterization of the genomic organization of a novel human ABC transporter, denoted ABCA9. Moreover, we provide evidence for the existence of multiple alternative ABCA9 transcripts and demonstrate their regulation in response to cholesterol flux in human macrophages.
ABCA9 cDNA and predicted polypeptide structure
Using an RT-PCR strategy based on large sets of degenerate primers homologous to human ABCA6 and ABCA8 (see Materials and methods), a 4.9-kb transcript containing a 4872-bp open reading frame was amplified from human macrophage cDNA. The detailed sequence has been deposited with the GenBank Database (Accession No. AF423307). The identified open reading frame encodes a 1624 amino acid polypeptide with a calculated molecular weight of approximately 160 kDa (Fig. 1) . Nucleotides 4600-4999 (relative to the translation start) of the predicted coding region showed >99% homology with a previously reported EST sequence (EST640918), referred to as ABCA9 [24] . Given this observation and in accordance with the currently proposed nomenclature for human ABC transporters, the novel protein was designated ABCA9. During the preparation of this manuscript, a study came to our attention demonstrating the identification of several ABC transporters on chromosome 17q24 [25] . Among others, a cDNA was reported for ABCA9 that is largely identical with, but at the 5 0 end, 45 bp shorter than the ABCA9 mRNA reported here. The ABCA9 molecule predicted by our results contains two NBF with the characteristic Walker A and B motifs and a signature sequence is present in the N-terminal NBF (Fig. 1) . However, similarly as observed for ABCA6 and ABCA8, respectively, no genuine signature sequence was identifiable in the C-terminal NBF. The ABCA9 amino acid sequence predicts the existence of two transmembrane domains, each consisting of seven membrane spanning segments. The length of the predicted ABCA9 polypeptide is similar to those observed for ABCA6 (1617 aa) and ABCA8 (1581 aa), respectively, but considerably shorter than that of the other human ABC A subfamily genes that have as yet been fully characterized. The latter include ABCA1 (2261 aa) [20] , ABCA2 (2436 aa) [17] , ABCR (2273 aa) [26] , and ABCA7 (2146 aa) [16] , respectively. Comparison of the predicted ABCA9 peptide sequence with cloned ABC full-size transporters revealed strikingly high homologies with human ABCA8 (72%) and ABCA6 (60%). In contrast, amino acid identities with other characterized human ABC A subfamily members including ABCA1 (32%), ABCA2 (32%), ABCR (31%), ABCA7 (34%), and ABCA3 (33%), respectively, were dramatically lower. The observations that the transporters ABCA9, ABCA8, and ABCA6 share extensive amino acid homologies and, at the same time, bear molecular features that clearly set them apart from the other known ABC A family members strongly support the view that these transporters constitute a distinct ABC transporter subclass within the ABC A subfamily. Based on their striking structural similarities and the finding that ABCA9, like ABCA8 and ABCA6, is located on a common genomic locus on chromosome 17q24 (see below), it is likely that all three transporter genes may have evolved from each other by gene duplication or have originated from a common ancestor to form a group of ABCA6-like transporters.
Identification of alternative ABCA9 mRNA variants in human macrophages
In the course of the cDNA cloning experiments, we were able to reproducibly amplify an additional band of 0.7 kb size from macrophage cDNA using primers spanning a segment near the 5 0 end of the ABCA9 coding region (base positions 303-910). Moreover, in our efforts to clone the 3 0 end of the ABCA9 mRNA, we consistently amplified three distinct bands ranging from 0.7 to 0.9 kb when primers were used that extended across cDNA positions 4171-4979 ( Fig. 2A) . Sequencing of the additional 0.7 kb band obtained from the 5 0 end of the coding region revealed that it was specific for ABCA9; however, it contained an additional 55 bp between base positions 800 and 801 of the canonical cDNA sequence (''ABCA9D þ 55''). Comparison with the genomic ABCA9 sequence (see below) showed that this site precisely represents the exon 6/exon 7 splice junction in the canonical ABCA9 transcript and that the additional 55-bp segment was completely identical to a sequence located at the 5 0 end of intron 6 (Figs. 2B and 4). The ABCA9D + 55 transcript is thus most likely generated through the partial retention of intron 6. Sequencing of the two additional bands obtained by PCR amplification of the segment corresponding to base pairs 4171-4979 demonstrated that the 0.8-kb band was identical with the canonical ABCA9 cDNA sequence. The 0.9-kb band differed from this sequence in that it contained a 73-bp insertion representing the entire intron 33 (''ABCA9D þ 73'') (Fig. 2B) . In contrast, we found that the short 0.7 kb band represented a transcript that completely lacked the 95 bp long exon 34 (''ABCA9D À 95'') ( Fig. 2B) , strongly suggesting that this transcript is a result of alternative exon skipping.
Interestingly, all three alternative ABCA9 transcripts we found induce frameshifts which ultimately introduce preterminal stops into the coding region. The ABCA9D + 55, ABCA9D + 73, and ABCA9D ) 95 transcripts thus predict the existence of three ABCA9 polypeptide variants of 266, 1440, and 1435 aa size, respectively (Fig. 2C) . The function of the alternatively spliced ABCA9 mRNAs is presently unclear. It remains to be established whether they represent regulatory mRNAs or whether they are translated in significant quantities into short ABCA9 polypeptide variants in tissues. Of particular interest in that context is the observation that the ABCA9D + 73 and ABCA9D À 95 transcripts code for truncated ABCA9 polypeptides that contain only one transmembrane domain and the Nterminal NBF (Fig. 2D ).
ABCA9 expression in human macrophages is suppressed by cholesterol overload
In previous studies, we demonstrated that the expression of a significant number of human ABC transporters in macrophages is regulated during monocyte differentiation into macrophages and by cellular cholesterol transport. Intriguingly, this group of cholesterol-responsive macrophage ABC transporters includes the majority of the cloned ABC A-subfamily members [12, 16, 17] . To test the hypothesis that gene expression of ABCA9 is regulated by sterol, freshly isolated human monocytes were allowed to differentiate into macrophages for four days in the presence of M-CSF and subsequently loaded with enzymatically modified LDL (eLDL) [21] for 24 h as previously described [17] . We found that the ABCA9 mRNA levels were upregulated during monocyte differentiation into macrophages (Fig. 3) . Importantly, loading of macrophages with eLDL strongly reduced the expression of the ABCA9 gene in macrophages (Fig. 3) . The induction of ABCA9 expression during M-CSF-dependent monocyte differentiation into macrophages and its suppression in response to sterol influx suggest roles for this transporter in macrophage lineage commitment and lipid homeostasis. One finding of note in our experiments is the consistent co-regulation of the canonical ABCA9 transcript and the ABCA9D þ 55 splice variant which supports the notion that the abundance of both mRNAs is controlled by common regulatory mechanisms.
Among the members of the human ABC A-subfamily, sterol-dependent suppression of gene expression has also been reported for the recently identified transporter ABCA6, a close homolog of ABCA9 [12, 18] . Presently, it is unclear whether the sterol-dependent inhibitory effect on the expression of both genes occurs at the transcriptional or post-transcriptional level. The identification and functional characterization of the ABCA6 and ABCA9 promoters will help elucidate the molecular mechanisms that underlie the cholesterol-responsive regulation of these structurally closely related ABC A-subclass transporters.
ABCA9 mRNA tissue distribution
The tissue-specific expression of ABCA9 was characterized using a multiple tissue RNA master blot containing mRNA from various human tissues. Dot blot analysis shows robust expression of human ABCA9 in a variety of tissues (Table 1) . Highest expression was found in heart, brain, and fetal tissues ( Table 1) . The tissue expression pattern of ABCA9 is similar to that observed for the structurally related transporter ABCA6 [18] . In contrast to the latter, however, ABCA9 exhibits significantly higher expression levels in fetal tissues, in particular, in the fetal heart and kidney which suggests potential roles for this transporter during the development of these organs.
ABCA9 gene structure and exon/intron boundaries
Amplification of the 5 0 end of the ABCA9 cDNA using primers from regions of maximum homology between the cDNAs of ABCA8 and ABCA6 revealed that the ABCA9 transcription initiation region is located >180 bp upstream of the translation start site. This strongly suggests that the ABCA9 full-length coding region starts in the proximity of the 5 0 end of exon 2. Based on this information, ABCA9 candidate introns were amplified from human genomic DNA using long template PCR. Exon-specific primers, based on the comparison of the known gene structures of human ABCA6 [18] , ABCA2 [17] , and ABCA1 [27] , respectively, were used which flanked putative ABCA9 exon/intron boundaries. The exon/intron organization of ABCA9 was assessed by direct sequencing of the respective PCR amplification products. The flanking regions of all intron spanning amplification products showed complete sequence identity with their respective cDNA counterparts. A total of 39 exons were thus identified ( Table 2 ). The complete exon sequences of ABCA9 have been deposited with the Gene expression levels for individual tissues were determined by dot blot analysis and quantitated densitometrically (Materials and methods). The signal densities were translated into a linear scale (0-4) and are shown as dots.
GenBank Database under Accession Nos. AF423308-AF423346. Exons and most introns are relatively small in size comparable to those in the ABCA6 gene. Exon sizes range from 56 to 227 bp and intron sizes are in the range from 73 to 11.8 kb ( Table 2 ). The initial and terminal dinucleotides of all introns showed the GT-AG configuration diagnostic of splice junctions [28] . We found that the 39 exons of the ABCA9 span a genomic region of approximately 85 kb (Fig. 4) . This structure is in accordance with the gene sizes reported for other human ABC A transporters (ABCA1, ABCA2, ABCR, ABCA6, and ABCA7) whose genomic regions range from 21 to 149 kb [17, 18, 27, 29, 30] .
Chromosomal assignment of the ABCA9 gene
GenBank database analyses using the FASTA algorithm revealed >99% identity of the whole assessed ABCA9 gene sequence with a genomic sequence (Accession No. AC005922). Using the Genome Browser software (http://genome.ucsc.edu), we allocated this contig to the chromosomal region 17q24.2-3, strongly suggesting that the ABCA9 gene is localized at this chromosomal site. Interestingly, we could assign the loci for the ABCA8 and ABCA6 genes, the closest known homologs of ABCA9, to the same chromosomal region. This indicates that the ABCA9, ABCA8, and ABCA6 genes share a common region on chromosome 17q24. Importantly, detailed screening of this genomic region for coding sequences revealed that two additional genes encoding bona fide ABC transporters co-localize to this very genomic microenvironment (manuscript in preparation).
In conclusion, we have identified a novel member of the ABC A-subfamily of full-size transporters, designated ABCA9, which represents the third member of the group of ABCA6-like ABC transporters. Moreover, we provide evidence for the existence of multiple mRNA variants potentially coding for truncated ABCA9 peptides in human macrophages. Our results demonstrating that the ABCA9 expression is induced during monocyte differentiation into macrophages and inhibited by cholesterol influx in human macrophages suggest that this novel transporter, like ABCA6, may serve functions in macrophage differentiation and lipid trafficking. Further work is required to determine the precise biological function of ABCA9 in transmembrane transport, in particular in the context with its close relatives ABCA8 and ABCA6. It will be particularly challenging to test whether and to which extent ABCA9 is implicated in fetal development.
